Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164

Completed · Phase 3

Conditions studied: Parkinson Disease

In brief

The purpose of this study is to obtain information on the long-term safety, tolerability, and therapeutic benefit of extended release ropinirole XL, and to provide a mechanism for patients who participated in either Study 167 or Study 164 to continue receiving ropinirole XL if they chose to do so.

Key facts

Study ID

NCT00650104

Run by

GlaxoSmithKline

People needed

76

Starts

2002-05-01

Expected to finish

2009-03-01

Last updated by the study team

2013-05-06

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or non-pregnant/non-breast feeding females
• At least 30 years of age
• Diagnosis of idiopathic Parkinson''s disease (Hoehn \& Yahr criteria)
• Completed either Study 167 or Study 164

You may not qualify if…

• Presence of uncontrolled psychiatric, hematological, renal, hepatic,endocrinological, neurological, cardiovascular disease or active malignancy
• Dizziness or fainting due to orthostatic hypotension on standing
• Significant sleep disorder
• Drug abuse or alcoholism

Where it is running

• GSK Investigational Site — Scottsdale, Arizona, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Oxnard, California, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Augusta, Georgia, United States
• GSK Investigational Site — Kansas City, Kansas, United States
• GSK Investigational Site — Edison, New Jersey, United States
• GSK Investigational Site — Upland, Pennsylvania, United States
• GSK Investigational Site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.